StockData
Palisade Bio, Inc. logo

Palisade Bio, Inc. (PALI) stock

PALINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$1.01−0.02 (-1.94%)

Close on Nov 17, 2026Market cap $176.01MP/E –Yield –

Palisade Bio cash

Cash and short-term investments held at the end of each period.

Palisade Bio's cash was $125.17M at Jun 30, 2026. For fiscal 2025 it was $133.39M, up 1258.2% from the year before. Over ten years it grew 27.0% a year on average. The highest annual figure on record is $133.39M in fiscal 2025.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$133.39M+1258.2%
FY2024Dec 31, 2024$9.82M-21.0%
FY2023Dec 31, 2023$12.43M+0.4%
FY2022Dec 31, 2022$12.38M+18.0%
FY2021Dec 31, 2021$10.50M+1371.9%
FY2020Dec 31, 2020$713.00K-86.1%
FY2019Dec 31, 2019$5.11M-11.6%
FY2018Dec 31, 2018$5.79M-50.5%
FY2017Dec 31, 2017$11.70M-42.1%
FY2016Dec 31, 2016$20.20M+65.1%
FY2015Dec 31, 2015$12.23M-55.6%
FY2014Dec 31, 2014$27.53M+63.4%
FY2013Dec 31, 2013$16.85M+126.3%
FY2012Dec 31, 2012$7.44M+216.5%
FY2011Dec 31, 2011$2.35M-74.6%
FY2010Dec 31, 2010$9.26M+301.0%
FY2009Dec 31, 2009$2.31M-52.9%
FY2008Dec 31, 2008$4.90M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$125.17M+2210.7%
Q1 FY2026Mar 31, 2026$132.63M+1734.4%
Q4 FY2025Dec 31, 2025$133.39M+1258.2%
Q3 FY2025Sep 30, 2025$5.23M-35.0%
Q2 FY2025Jun 30, 2025$5.42M-52.3%
Q1 FY2025Mar 31, 2025$7.23M-35.9%
Q4 FY2024Dec 31, 2024$9.82M-21.0%
Q3 FY2024Sep 30, 2024$8.04M-47.5%
Q2 FY2024Jun 30, 2024$11.35M-30.8%
Q1 FY2024Mar 31, 2024$11.28M-15.2%
Q4 FY2023Dec 31, 2023$12.43M+0.4%
Q3 FY2023Sep 30, 2023$15.31M+9.5%
Q2 FY2023Jun 30, 2023$16.40M+229.4%
Q1 FY2023Mar 31, 2023$13.30M+100.1%
Q4 FY2022Dec 31, 2022$12.38M+18.0%
Q3 FY2022Sep 30, 2022$13.99M-0.8%
Q2 FY2022Jun 30, 2022$4.98M-60.6%
Q1 FY2022Mar 31, 2022$6.64M+980.3%
Q4 FY2021Dec 31, 2021$10.50M+1371.9%
Q3 FY2021Sep 30, 2021$14.10M+1778.0%
Q2 FY2021Jun 30, 2021$12.65M+733.0%
Q1 FY2021Mar 31, 2021$615.00K-93.9%
Q4 FY2020Dec 31, 2020$713.00K-86.1%
Q3 FY2020Sep 30, 2020$751.00K-89.7%
Q2 FY2020Jun 30, 2020$1.52M-33.4%
Q1 FY2020Mar 31, 2020$10.03M+150.4%
Q4 FY2019Dec 31, 2019$5.11M-11.6%
Q3 FY2019Sep 30, 2019$7.30M+27.2%
Q2 FY2019Jun 30, 2019$2.28M-67.8%
Q1 FY2019Mar 31, 2019$4.01M-58.8%
Q4 FY2018Dec 31, 2018$5.79M-50.5%
Q3 FY2018Sep 30, 2018$5.74M-59.3%
Q2 FY2018Jun 30, 2018$7.09M-37.8%
Q1 FY2018Mar 31, 2018$9.72M-41.8%
Q4 FY2017Dec 31, 2017$11.70M-42.1%
Q3 FY2017Sep 30, 2017$14.10M+147.4%
Q2 FY2017Jun 30, 2017$11.40M–
Q1 FY2017Mar 31, 2017$16.70M–
Q4 FY2016Dec 31, 2016$20.20M–
Q3 FY2016Sep 30, 2016$5.70M–

More Palisade Bio figures

See a number that looks wrong?